Crocs (CROX)
Consumer · NASDAQ · US
Price as at 5 Sept 2026, 02:33 UTC. Quotes are delayed.
Fundamentals
Valuation and ratings
Crocs trades at $117.53, which is 55% above the $53.11 our fair value estimate puts on the business. On that measure it screens as expensive, which is not the same as saying it will fall.
Our moat model scores it 37 out of 100, which is little in the way of a moat. A moat is a structural reason competitors cannot take the profits away, and it matters more to a long holding period than any single quarter's numbers do.
CROX earnings and analyst estimates
Recommendation mix, 15 published ratings
Estimates are the published analyst consensus and move often. An earnings date is scheduled, not certain, and a share tends to reprice most violently on the day itself.
About Crocs
Crocs, Inc. together with its subsidiaries, designs, develops, manufactures, markets, distributes, and sells casual lifestyle footwear and accessories for men, women, and kids under the Crocs and HEYDUDE Brands in the United States and internationally. The company offers various footwear products, including clogs, sandals, loafers, classics, fuzz, platforms, boots, sandals, slides, slippers, sneakers, flip flops, and flats, as well as totes, backpacks, belt bags, socks, bag charms, cases, attachments, cartoon characters products, and touchland and other accessories. It sells its products through wholesalers, retail stores, e-commerce sites, third-party marketplaces, outlet stores, and kiosks/store-in-store locations. Crocs, Inc. was founded in 1999 and is headquartered in Broomfield, Colorado.
Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.
Super investor ownership
18 of the funds we track reported a position in their latest SEC 13F filing. Largest first:
- Ken Griffin, CITADEL ADVISORS LLC$132.60M · 0.0% of book
- Steve Cohen, Point72 Asset Management, L.P.$107.68M · 0.1% of book
- Li Lu, Himalaya Capital Management LLC$107.02M · 2.9% of book
- D. E. Shaw, D. E. Shaw & Co., Inc.$104.90M · 0.1% of book
- Samantha McLemore, Patient Capital Management, LLC$96.44M · 3.2% of book
A word of warning on reading these figures: a 13F reports the market value of a holding, so a fund that traded nothing at all still appears to have sold when the price fell. We found 102 companies where the standard reading gives the opposite answer. Only the share count is honest.
Common questions
Is Crocs (CROX) undervalued?
Against our fair value estimate of $53.11, CROX at $117.53 is 55% above fair value. That is one model's answer, not a recommendation. It is built from normalized earning power with growth capped deliberately low, which understates companies whose value is mostly future growth.
Which funds own CROX?
18 of the institutions we track reported a position in CROX in their most recent SEC 13F filing. A 13F is filed up to 45 days after quarter end, so it tells you what a fund held then, not what it holds now.
Where does SteadyShares get its CROX data?
Fundamentals for CROX come from company filings and exchange data, as listed on NASDAQ; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 5 Sept 2026, 02:33 UTC and is delayed. Metrics we do not hold are left out of the page rather than estimated.
The full research page for CROX, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.